Literature DB >> 19697519

Does neoadjuvant chemotherapy for breast cancer increase complications during immediate breast reconstruction?

Ying Liu1, Hiroki Mori, Yuiro Hata.   

Abstract

BACKGROUND: Neoadjuvant chemotherapy (NAC) has been administered since the 1990s and is now one of the major treatments for breast cancer. It can achieve extremely positive results in some patients. Whether NAC affects immediate breast reconstruction (IBR) using an expander, however, remains unclear.
METHODS: A retrospective study was performed at Tokyo Medical and Dental University (TMDU) hospital. Seventy-five cases of immediate breast reconstruction using an expander were performed in 69 patients between January 2001 and January 2007. The patients were evaluated for tumor size, histological type, sites of invasion, staging, lymph node metastasis, NAC regimen, response to NAC, type of immediate breast reconstruction (IBR), complications, and prognosis.
RESULTS: In patients treated with an expander, there was no significant difference in the complication rate between those who underwent NAC and those who did not.
CONCLUSIONS: NAC did not increase the complication rate after IBR using an expander. However, for reconstruction using autologous tissue, more data are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19697519

Source DB:  PubMed          Journal:  J Med Dent Sci        ISSN: 1342-8810


  2 in total

1.  Short- and long-term outcomes of immediate breast reconstruction surgery after neoadjuvant chemotherapy.

Authors:  Toshiyuki Ishiba; Tomoyuki Aruga; Hiromi Miyamoto; Sakiko Ishihara; Miyako Nara; Mio Adachi; Yuichi Kumaki; Chiaki Saita; Mai Onishi; Risa Goto; Naoko Iwamoto; Rika Yonekura; Yayoi Honda; Miwako Fujii; Shoichi Tomita; Shinichiro Horiguchi; Goshi Oda; Tsuyoshi Nakagawa; Tomoyuki Fujioka; Yasunobu Terao
Journal:  Surg Today       Date:  2021-06-05       Impact factor: 2.549

2.  Impact of neoadjuvant chemotherapy on immediate breast reconstruction: a meta-analysis.

Authors:  Junlong Song; Xiang Zhang; Qiang Liu; Jianheng Peng; Xinjie Liang; Yuanyuan Shen; Hongtao Liu; Hongyuan Li
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.